A case of primary hepatic extranodal marginal zone B-cell mucosa-associated lymphoid tissue (MALT) lymphoma treated by radiofrequency ablation (RFA), and a literature review

J Int Med Res. 2021 Mar;49(3):300060521999539. doi: 10.1177/0300060521999539.

Abstract

Primary hepatic mucosa-associated lymphoid tissue (MALT) lymphoma is an extremely rare liver malignancy that usually lacks characteristic imaging findings and which is often misdiagnosed. We report a 63-year-old woman diagnosed with primary hepatic extranodal marginal zone B-cell lymphoma, MALT type. The patient underwent needle biopsy and radiofrequency ablation (RFA), and showed no signs of relapse during the 12-month postoperative follow-up. This case stresses the rarity of primary hepatic MALT-type lymphoma and the unique and effective treatment for this patient. Our patient received RFA, which showed good efficacy and which provides a new option for the treatment of hepatic MALT lymphoma. We also present our findings from a systematic review to improve the current understanding of this disease.

Keywords: Primary hepatic lymphoma; cancer; fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography; marginal zone B-cell lymphoma; mucosa-associated lymphoid tissue lymphoma; radiofrequency ablation.

Publication types

  • Case Reports
  • Systematic Review

MeSH terms

  • B-Lymphocytes
  • Female
  • Humans
  • Lymphoid Tissue
  • Lymphoma, B-Cell, Marginal Zone* / diagnostic imaging
  • Lymphoma, B-Cell, Marginal Zone* / surgery
  • Middle Aged
  • Mucous Membrane
  • Neoplasm Recurrence, Local
  • Radiofrequency Ablation*